Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Skymizerʼs HyperThought™ Wins "Best IP/Processor of the Yearˮ and "Most Promising Productˮ at EE Awards Asia 2025
-
Flame On Catering: Bringing Live BBQ & Multicultural Dining to Modern Events
-
Law Mother Announces Launch of "Wealthy Ever After" Book by Pam Maass Garrett
-
Hooked Launches AI-Powered Video Creation Platform for Effortless Content Scaling
-
Finaive Announces AI-Powered Fraud Prevention System for Digital Commerce
-
Christina Galbraith Global Decor Launches a Platform for Interior Design from Underrepresented Geographies
-
Generative AI Meets Personal Branding: Jerry Hsu’s Disruptive Model for 2025 and Beyond
-
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
-
Precision CNC Machining at Its Finest: From Prototype to Production with SogaWorks
-
Monster Energy's Ayumu Hirano and Brendan Mackay Earn Victories at The Snow League Halfpipe Competition in China
-
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
-
SALI Showcases Global Ambition with Times Square Billboard Campaign, Marking a New Milestone in Its Journey Toward a Global Power Tool Accessories Empire
-
Memphis Shines as Thousands Unite for St. Jude Memphis Marathon Weekend
-
SK hynix Honored with Two Major Titles at GSA Awards 2025
-
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
-
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual M
-
MENU - ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
-
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
-
Discount Tire Celebrates Inter Miami CF MLS Cup Championship
-
Former Candidate Bill Reicherter Endorses Maria Zack for Florida House District 90
-
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
-
TheOther Debuts Premium Matcha at an Intimate Art Basel Celebration in Miami Co-Hosted By Central Cee
-
Lustock: A Modern Trading Hub Built for Professional and Retail Investors
-
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC
-
From Studio to Catwalk: Music Inspires Dime City Apparel’s Designs
-
Best Place to Buy Rugs (2025): Rugs Direct Recognized for Quality, Selection and Style by Expert Consumers
-
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
-
Strength-Based ADHD Testing for Teens and Adults Who Were Never Diagnosed: Validation, Understanding, and New Possibilities
-
Best HR and Payroll Software (2025): QuickBooks Awarded for Accuracy and Team Management by Better Business Advice
-
Raythink Ranks 9th in 2025 a&s Security 50, Showcasing AI-Driven Thermal Imaging & Security Solutions
-
XRP Price Today: Is Remittix the Reason Other Cryptos Price Isn’t Increasing Despite Expansion?
-
Is Dogecoin Price Attainable? Analysts Pick 3 Sub Tokens Likely to Lead The Charge
-
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
-
Bitcoin Outlook for 2026: Can BTC Bounce Back in 2026? AI Predicts Remittix To Grow
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Hep B Free - Calls for Continued Universal Hepatitis B Birth-Dose Vaccination Despite Federal Advisory Shift
-
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
-
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
-
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
-
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
-
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
-
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
-
Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for November 2025
-
Mudcup 2025 (The Eighth Edition) Was A Smashing Success!
-
GJK Facilities Announces Scholarship to Support Aspiring Aerospace Engineer
-
Elysium Wealth Advisors Expands Services for Expatriates Across Europe
-
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
-
BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program
-
Roofing Expert Keith Miller Clarifies Why Flashing Is the Source of Many Roof Leaks in HelloNation
